275 related articles for article (PubMed ID: 28963908)
21. Novel variants in
Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
Moriyama T; Yang W; Smith C; Pui CH; Evans WE; Relling MV; Bhatia S; Yang JJ
Pharmacogenet Genomics; 2022 Feb; 32(2):60-66. PubMed ID: 34412101
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474
[TBL] [Abstract][Full Text] [Related]
24. [Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].
Hao QS; Wang Z; Fang QY; Gong XY; Liu KQ; Li Y; Wei H; Wang Y; Li QH; Wang M; Tian Z; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):911-916. PubMed ID: 35045652
[No Abstract] [Full Text] [Related]
25. Mercaptopurine induced myelosuppression in a child with a
Gupta N; Magatha LS; Jayaraman D; Scott JX; Antony SB; Koshy T
J Oncol Pharm Pract; 2023 Jun; 29(4):999-1001. PubMed ID: 36341754
[TBL] [Abstract][Full Text] [Related]
26. [Severe 6-mercaptopurine-induced hematotoxicity in childhood an ALL patient with homozygous NUDT15 missence variants].
Kimura S; Hasegawa D; Yoshimoto Y; Hirabayashi S; Hosoya Y; Yoshihara H; Kumamoto T; Tanaka Y; Manabe A
Rinsho Ketsueki; 2016 Jun; 57(6):748-53. PubMed ID: 27384855
[TBL] [Abstract][Full Text] [Related]
27. [Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].
He J; Liu L
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):100-104. PubMed ID: 30675872
[TBL] [Abstract][Full Text] [Related]
28. NUDT15 polymorphism in healthy children with Bai nationality in Yunnan of China.
Pu G; Wang Y; Duan S; Chen J; Yang C; Cui T; Fang C; Zhou Y; Zhang H; Tian X
Pediatr Int; 2021 Jul; 63(7):790-796. PubMed ID: 32969567
[TBL] [Abstract][Full Text] [Related]
29. Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia.
Naushad SM; Dorababu P; Rupasree Y; Pavani A; Raghunadharao D; Hussain T; Alrokayan SA; Kutala VK
Cancer Chemother Pharmacol; 2019 May; 83(5):875-880. PubMed ID: 30806759
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
Kakuta Y; Kinouchi Y; Shimosegawa T
J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
[TBL] [Abstract][Full Text] [Related]
31. NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia.
Yi ES; Choi YB; Choi R; Lee NH; Lee JW; Yoo KH; Sung KW; Lee SY; Koo HH
Cancer Res Treat; 2018 Jul; 50(3):872-882. PubMed ID: 28903549
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.
Stocco G; Cheok MH; Crews KR; Dervieux T; French D; Pei D; Yang W; Cheng C; Pui CH; Relling MV; Evans WE
Clin Pharmacol Ther; 2009 Feb; 85(2):164-72. PubMed ID: 18685564
[TBL] [Abstract][Full Text] [Related]
33. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay.
Soler AM; Olano N; Méndez Y; Lopes A; Silveira A; Dabezies A; Castillo L; da Luz JA
Br J Haematol; 2018 Apr; 181(2):252-255. PubMed ID: 28146264
[No Abstract] [Full Text] [Related]
34. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
[TBL] [Abstract][Full Text] [Related]
35. Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment.
Kouwenberg TW; van den Bosch BJC; Bierau J; Te Loo DMWM; Coenen MJH; Hagleitner MM
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e94-e97. PubMed ID: 31895215
[TBL] [Abstract][Full Text] [Related]
36. Prominence of NUDT15 genetic variation associated with 6-mercaptopurine tolerance in a genome-wide association study of Japanese children with acute lymphoblastic leukaemia.
Tanaka Y; Urayama KY; Mori M; Arakawa Y; Hasegawa D; Noguchi Y; Yanagimachi M; Keino D; Ota S; Akahane K; Inukai T; Hangai M; Kawaguchi T; Takagi M; Koh K; Matsuda F; Manabe A
Br J Haematol; 2022 Oct; 199(2):260-269. PubMed ID: 35961941
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.
Farfan MJ; Salas C; Canales C; Silva F; Villarroel M; Kopp K; Torres JP; Santolaya ME; Morales J
BMC Cancer; 2014 Apr; 14():299. PubMed ID: 24774509
[TBL] [Abstract][Full Text] [Related]
38. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.
Dorababu P; Nagesh N; Linga VG; Gundeti S; Kutala VK; Reddanna P; Digumarti R
Eur J Clin Pharmacol; 2012 Apr; 68(4):379-87. PubMed ID: 22009189
[TBL] [Abstract][Full Text] [Related]
39. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.
Ma X; Zheng J; Jin M; Li W; Gao C; Zhang D; Chen Y; Li X; Xie J
Int J Clin Exp Pathol; 2014; 7(7):4552-6. PubMed ID: 25120852
[TBL] [Abstract][Full Text] [Related]
40. Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients.
Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Raghav L; Chang HH; Wu KH; Chou SW; Ni YL; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2020 Sep; 10(1):14400. PubMed ID: 32873882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]